Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 1/20 | 0.88 |
| ▸ | LMNA | P02545 | 5/20 | 0.56 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.56 |
| ▸ | OR51E2 | Q9H255 | 2/20 | 0.56 |
| ▸ | LDHA | P00338 | 3/20 | 0.55 |
| ▸ | LDHB | P07195 | 1/20 | 0.55 |
| ▸ | BLM | P54132 | 5/20 | 0.46 |
| ▸ | PMP22 | Q01453 | 4/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.46 |
| ▸ | CA2 | P00918 | 2/20 | 0.44 |
| ▸ | CA9 | Q16790 | 2/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | THPO | P40225 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Carbamic Acid SCHEMBL453944 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL304822 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL7077008 | 1.00 | ACHE (0.88) | ACHELMNAALDH1A1TDP1OR51E2 | |
| Carbamic Acid SCHEMBL49149 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL11773571 | 1.00 | ACHE (0.88) | ACHELMNAALDH1A1TDP1OR51E2 | |
| Carbamic Acid SCHEMBL27778731 | 1.00 | — | — | |
| Carbamic Acid SCHEMBL28049031 | 1.00 | ACHE (0.88) | ACHELMNAALDH1A1TDP1OR51E2 | |
| Carbamic Acid SCHEMBL7077007 | 1.00 | ACHE (0.88) | ACHELMNAALDH1A1TDP1OR51E2 | |
| Carbamic Acid SCHEMBL3862844 | 0.94 | — | — | |
| Carbamic Acid SCHEMBL9118128 | 0.94 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117466815-A | Synthesis method of azaanthrone compound | 西北工业大学 | 2024-01-30 | — | — | CN | claimed |
| CN-117466815-A | Synthesis method of azaanthrone compound | 西北工业大学 | 2024-01-30 | — | — | CN | disclosed |
| US-20220298161-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | SPIROGEN SARL (CH) | 2022-09-22 | — | — | US | disclosed |
| US-11135303-B2 | Pyrrolobenzodiazepines and conjugates thereof | MEDIMMUNE LIMITED (GB) | 2021-10-05 | — | — | US | disclosed |
| CN-112772393-A | Method for amphibious fallow in farmland | 上海开太鱼文化发展有限公司 | 2021-05-11 | — | — | CN | disclosed |
| EP-2970340-B1 | BETA-LACTAMASE INHIBITORS | VENATORX PHARMACEUTICALS INC (US) | 2020-02-12 | — | — | EP | disclosed |
| US-10294248-B2 | Beta-lactamase inhibitors | VenatoRx Pharmaceuticals, Inc. (US) | 2019-05-21 | — | — | US | disclosed |
| CN-106164191-B | Paint resin combination, formed body, image display device | 捷恩智株式会社 | 2019-04-12 | — | — | CN | disclosed |
| US-20180273552-A1 | BETA-LACTAMASE INHIBITORS | NATIONAL INSTITUTES OF HEALTH | 2018-09-27 | — | — | US | disclosed |
| US-20180134717-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | SPIROGEN LIMITED (GB) | 2018-05-17 | — | — | US | disclosed |
| US-20120053342-A1 | METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2012-03-01 | — | — | US | disclosed |
| US-8058469-B2 | Method for making carbamates, ureas and isocyanates | SABIC INNOVATIVE PLASTICS IP B.V. (NL) | 2011-11-15 | — | — | US | disclosed |
| WO-2011130598-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | SPIROGEN LIMITED (GB) | 2011-10-20 | — | — | WO | disclosed |
| US-20110256157-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | SPIROGEN LIMITED (GB) | 2011-10-20 | — | — | US | disclosed |
| EP-2362867-A2 | METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES | SABIC Innovative Plastics IP B.V. (NL) | 2011-09-07 | — | — | EP | disclosed |
| CN-1270889-C | Buffer derive including improved flexible partition film | NIKE INTERNAT CO LTD (US) | 2006-08-23 | — | — | CN | disclosed |
| CN-1054261-C | Plant treatment agents | BAYER AGROCHEM KK (JP) | 2000-07-12 | — | — | CN | disclosed |
| CN-1046723-C | Tetracyclic compounds as dopamine agonists | ABBOTT LAB (US) | 1999-11-24 | — | — | CN | disclosed |
| CN-1124489-A | Tetracyclic compounds as dopamine agonists | ABBOTT LAB (US) | 1996-06-12 | — | — | CN | disclosed |
| CN-1078850-A | The method of control harmful insect | BAYER AGROCHEM KK (JP) | 1993-12-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180273552-A1 | BETA-LACTAMASE INHIBITORS | MGAM, GAA, LCT | ACHE 13/4885LMNA 542/4885ALDH1A1 305/4885 |
| US-10294248-B2 | Beta-lactamase inhibitors | MGAM, GAA, LCT | ACHE 13/4885LMNA 542/4885ALDH1A1 305/4885 |
| US-20110256157-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | HDAC10, PBDC1, PDCD10 | ACHE 4855/4885LMNA 2456/4885ALDH1A1 1192/4885 |
| US-20180134717-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | HDAC10, PBDC1, PDCD10 | ACHE 4855/4885LMNA 2456/4885ALDH1A1 1192/4885 |
| US-11135303-B2 | Pyrrolobenzodiazepines and conjugates thereof | CD79B, BCL6B, DRD1 | ACHE 3134/4885LMNA 3435/4885ALDH1A1 1055/4885 |
| US-20220298161-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF | HDAC10, PBDC1, PDCD10 | ACHE 4855/4885LMNA 2456/4885ALDH1A1 1192/4885 |
| US-20120053342-A1 | METHOD FOR MAKING CARBAMATES, UREAS AND ISOCYANATES | CPS1, ALKBH3, IDH3A | ACHE 35/4885LMNA 2106/4885ALDH1A1 2343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.